Arcadia Investment Management Corp Abb Vie Inc. Transaction History

Arcadia Investment Management Corp

$606 Million
Q3 2024

A detailed history of Arcadia Investment Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Arcadia Investment Management Corp holds 7,680 shares of ABBV stock, worth $1.38 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

7,680

Previous 7,700 0.26%

Holding current value

$1.38 Million

Previous $1.32 Million 14.85%

% of portfolio

0.25%

Previous 0.23%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$163.84 - $199.33 $3,276 - $3,986	-20 Reduced 0.26%	7,680 $1.52 Million
Q2 2024 Aug 05, 2024	SELL	$154.79 - $180.76 $258,654 - $302,049	-1,671 Reduced 17.83%	7,700 $1.32 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $9,429 - $10,743	59 Added 0.63%	9,371 $1.71 Million
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $229,241 - $258,180	1,666 Added 21.79%	9,312 $1.44 Million
Q2 2023 Jul 24, 2023	SELL	$132.51 - $164.9 $611,136 - $760,518	-4,612 Reduced 37.62%	7,646 $1.03 Million
Q1 2023 May 05, 2023	SELL	$144.61 - $166.54 $39,767 - $45,798	-275 Reduced 2.19%	12,258 $1.95 Million
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $539,685 - $647,224	3,902 Added 45.21%	12,533 $2.03 Million
Q3 2022 Oct 19, 2022	SELL	$134.21 - $153.93 $38,920 - $44,639	-290 Reduced 3.25%	8,631 $1.16 Million
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $29,313 - $37,266	213 Added 2.45%	8,921 $1.37 Million
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $54,507 - $67,628	413 Added 4.98%	8,708 $1.41 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $113,338 - $143,406	1,055 Added 14.57%	8,295 $1.12 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $26,600 - $30,195	-250 Reduced 3.34%	7,240 $781,000
Q2 2021 Aug 02, 2021	SELL	$105.21 - $117.21 $76,277 - $84,977	-725 Reduced 8.83%	7,490 $844,000
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $30,690 - $33,786	-300 Reduced 3.52%	8,215 $889,000
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $376,290 - $508,032	-4,675 Reduced 35.44%	8,515 $912,000
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $70,875 - $83,184	-825 Reduced 5.89%	13,190 $1.16 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $66,033 - $88,362	-900 Reduced 6.03%	14,015 $1.38 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $101,587 - $154,019	-1,575 Reduced 9.55%	14,915 $1.14 Million
Q4 2019 Jan 29, 2020	SELL	$72.13 - $90.25 $491,926 - $615,505	-6,820 Reduced 29.26%	16,490 $1.46 Million
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $169,038 - $203,232	-2,684 Reduced 10.33%	23,310 $1.77 Million
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $2.14 Million - $2.74 Million	-32,639 Reduced 55.67%	25,994 $1.89 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $441,626 - $519,772	-5,725 Reduced 8.9%	58,633 $4.73 Million
Q4 2018 Jan 17, 2019	SELL	$77.85 - $96.01 $452,542 - $558,106	-5,813 Reduced 8.28%	64,358 $5.93 Million
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $1.17 Million - $1.3 Million	-13,193 Reduced 15.83%	70,171 $6.64 Million
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $1.4 Million - $1.65 Million	-15,557 Reduced 15.73%	83,364 $7.72 Million
Q1 2018 Apr 19, 2018	SELL	$92.01 - $123.21 $242,906 - $325,274	-2,640 Reduced 2.6%	98,921 $9.36 Million
Q4 2017 Jan 30, 2018	BUY	$89.56 - $98.21 $274,949 - $301,504	3,070 Added 3.12%	101,561 $9.82 Million
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $6.88 Million - $8.79 Million	98,491	98,491 $8.75 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Management Corp with notifications on news.

Account

Arcadia Investment Management Corp Abb Vie Inc. Transaction History